Intravenous thrombolysis (IVT) for stroke is currently supported by evidence up to 4.5 hours after stroke onset or 9 hours with mismatch imaging selection. Trials of IVT in the 4.5–24-hour window have shown mixed results in different subgroups.
This meta-analysis showed that IVT alone improves outcomes up to 24 hours, but uncertainty remains in those patients who undergo endovascular thrombectomy (EVT).
This work supports change in guidelines for IVT up to 24 hours after stroke in patients where EVT is not indicated or available. Trials of IVT before EVT in the late window are needed.
Level 1 evidence from randomised trials supports intravenous thrombolysis (IVT) for acute ischaemic stroke with clear benefit up to 4.5 hours after symptom onset,